Antiphospholipid antibodies;Anticuerpos antifosfolipido

Revista Espanola de Reumatologia

Volumn 23, Issue 9, 1996, Pages 389-395

  Cuadrado, María José ^a   Amengual, Olga ^b   Khamashta, Munther A ^b  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN ANTIBODY; PHOSPHOLIPID ANTIBODY;

ANTIPHOSPHOLIPID SYNDROME; CONNECTIVE TISSUE DISEASE; HUMAN; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS;

EID: 0030464761     PISSN: 03044815     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. Harris EN, Gharavi AE, Boyle ML et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983; 2: 1.211-1.214.
2. Triplett DA, Brand JT. Lupus anticoagulants, misnomer, paradox, riddle, epiphenomenon. Haematol Pathol 1988; 2: 121-123.
3. Bevers EM, Galh M, Barbui T, Comfurius P, Zwall RFA Lupus anticoagulant IgGs (LA) are not directed to phospholipids only but to a complex of lipid bound prothrombin. Thromb Haemost 1991; 66: 629-632.
4. McNeil HP, Simpson RJ, Chesterman CN, Krilis SA. Antiphospholipid antibodies are directed against a complex antigen that includes a lipid binding inhibitor of coagulation: beta 2 glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 1990, 87: 4.120-4.124.
5. Ichikawa K, Khamashta MA, Koike T, Matsuura E, Hughes GRV. Beta 2-glycoprotein 1 reactivity of monoclonal anticardiolipin antibodies from patients with the antiphosphohpid syndrome. Arthritis Rheum 1994; 37: 1.453-1.461.
6. Hughes GRV. The anticardiolipin syndrome. Clin Exp Rheumatol 1985; 3. 285-286.
7. Lewkonia RM. Origin of antiphospholipid antibody syndrome. J Rheumatol 1995; 22 186-187.
8. Khamashta MA. El síndrome de Hughes, síndrome anticardiolipina o sídrome antifosfolípido. Rev Clin Esp 1995; 195. 5-7
9. Khamashta MA, Asherson RA Hughes syndrome, antiphospholiptd antibodies move closer to thrombosis in 1994. Br J Rheumatol 1995. 34 493-494.
10. Khamashta MA, Cuadrado MJ Tratamiento del síndrome de Hughes o síndrome antifosfolípiclo. Rev Esp Reumatol 1995; 22. 339-343
11. Hunt BJ, Khamashta MA. Management of the Hughes syndrome Clin Exp Rheumatol 1996; 14: 115-117
12. Harris EN Diagnosis and management of antiphospholipid syndrome Hosp Pract 1994; 264. 7.944-7.949.
13. Exner T, Triplett DA, Taberner D, Machin SJ. Guideline for testing and revised criteria for lupus anticoagulants SSC Subcommitee for the standarization of lupus anticoagulants. Thromb Haemost 1991; 65: 320-322.
14. Lupus Anticoagulant Working Party of BCSH Haemostasis and Thrombosis Task Force. Guideliness on testing for the lupus anticoagulant J Clin Pathol 1991; 44 885-889
15. Brandt JT, Triplett DA. Rock WA, Bovill EG, Arkin CF Effect of lupus anticoagulants on the activated partial thromboplastin time. Arch Pathol Lab Med 1991, 115; 109-114
16. Malia RG, Cooper SM, Faulkner K, Greaves M. The specificity of the platelet neutralization procedures for lupus anticoagulant detection. Thromb Haemost 1993; 69: 1.221.
17. Galli M, Comfurius P, Maasen C et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990; 335 1.544-1.547.
18. Matsuura E, Igarashi Y, Fujimoto M, Ichikawa K. Koike T Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease Lancet 1990; 336: 177-178
19. Schousboe I. Beta-2-glycoprotein I. a plasma inhibitor of the contact activation of the intrinssic blood coagulation pathway. Blood 1985; 66: 1.086-1 091.
20. Keeling DM, Wilson AJG, Mackie IJ et al. Role of beta 2-glycoprotein I and antiphospholipid antibodies in activation of protein C in vitro J Clin Pathol 1993, 46. 908-911.
21. Hunt J. McNeil HP, Morgan GJ, Crameri RM, Krilis SA. A phospholipid-beta 2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection. Lupus 1992; 2: 75-81.
22. Galli M, Comfurius P, Barbui T et al Anticoagulant activity of beta 2-glycoprotein I is potentiated by a distinct subgroup of anticardiolipin antibodies. Thromb Hemost 1992; 68: 297300.
23. Moore JE, Lutz WB The natural history of systemic lupus erythematosus. an approach to its study through chronic biologic false positive reactors J Chron Dis 1995; 1: 297.
24. Alarcón-Segovia D, Osmundson PJ Peripheral vascular syndromes associated with systemic lupus erythematosus. Ann Intern Med 1965, 62: 907-919.
25. Bowie EJW, Thompson JH Jr, Pascuzzi CA, Owen CA. Thrombosis in systemic lupus erythematosus despite circulating anticoagulants J Clin Med 1963, 62. 4l6.
26. Alarcón-Segovia D, Sánchez-Guerrero J. Primary antiphospholipid syndrome J Rheumatol 1989; 16: 482-488.
27. Mackworth-Young CG. Loizou S, Walport MJ. Primary antiphospholipid syndrome, features of patients with raised anticardiolipin antibodies and no other disorder. Ann Rheum Dis 1989. 48. 352-357
28. Asherson RA, Khamashta MA, Ordi-Ros J et al. The primary antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) 1989; 68: 366-374
29. Font J, Lopez-Soto A. Cervera R et al The primary antiphospholipid syndrome antiphospholipid antibody pattern and clinical features of a series of 23 patients. Autoimmunity 1991: 9:69-75
30. Harris EN. Annotation. Antiphospholipid antibodies. Br J Haematol 1990. 74: 1-9
31. Alarcón-Segovia D, Delezé M, Oria CV et al Amiphosphohpid antibodies and the antiphospholipid syndrome m systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine (Baltimore) 1989: 68: 353365
32. Vianna JL. Khamashta MA, Orcli-Ros J et al. Comparison of the primary and secondary antiphospholipid syndrome a European multicentre study of 114 patients. Am J Med 1994, 96: 3-9.
33. Asherson RA. Doherty DG, Vergam D. Khamasthta MA. Hughes GRV. Major histocompatibility complex associations with the primary antiphospholipid syndrome. Arthritis Rheum 1992, 35: 1.124-1.125
34. Camps MT, Cuadrado MJ, Ocón P et al. Association between HLA class II antigens and primary antiphospholipid syndrome from the South of Spain. Lupus 1995, 4: 51-55.
35. Camps MT, Cuadrado MJ, Ocón P, Sánchez-Lora J, Guil M, De Ramón E Genetic differences between primary and secondary antiphospholipid syndrome. Am J Med 1996; 101 (sometido).
36. Mujic F, Cuadrado MJ, Lloyd M, Khamastha MA, Hughes GRV Primary antiphospholipid syndrome (PAPS) evolving into systemic lupus erythematosus (SLE) J Rheumatol 1995; 22: 1 589-1 592.
37. Monteagudo M, Montalb́n J, Álvarez J et al. Stroke and anticardiolipin antibodies in a patient with rheumatoid arthritis and large granular lymphocyte proliferation. J Rheumatol 1988; 15 1.589-1 590.
38. Shapiro LS. Large vessel arterial thrombus in systemic sclerosis associated with antiphospholipid antibodies J Rheumatol 1990; 17. 685-688.
39. Ingram SB, Goodnight SH. Bennet RM. An anusual syndrome of devastating non inflammatory vasculopathy associated with anticardiolipin antibodies: a report of two cases. Arthritis Rheurn 1987, 30: 1.107-1.171
40. Espinoza LR, Jara JL, Silveira LH et al. Anticardiolipm antibodies in polymialgia rheumatica-giant cell arteritis: association with severe vascular complications Am J Med 1991; 90: 474478
41. Cid MC. Cervera R, Font J, Campo E, López-Soto A. Recurrent arterial thrombosis in a patient with giant cell arteritis and raised anticardiolipm antibody level Br J Rheumatol 27: 164-166
42. Mateo L, Juanola X, Nolla JM et al. Síndrome antifosfolípido en pacientes afectos de espondilitis anquilosante. Presentaciön de dos casos. Med Clin (Barc) 1992; 98: 381-383
43. Vianna J, D'Cruz D, Khamashta MA. Asherson RA, Hughes GRV. Anticardiolipin antibodies in a patient with Crohn's disease and thrombosis Clin Exp Rheumatol 1992, 10: 165168.
44. Font J. Cervera R, López-Soto A et al Anticardiolipin antibodies in patients with autoimmune diseases, isotype distribution and clinical association. Clin Rheumatol 1989, 8. 475-483
45. Naldi K, Finazzi G, Brevi A et al. Antiphospholipid antibodies and melanoma, a link? Dermatology 1992, 22 1 3961.398
46. Shaukat MN, Hughes P. Recurrent thrombus and anticardiolipin antibodies associated with adenocarcinoma of the lung Postgrad Med 1990; 66 316-319.
47. Canoso RT, De Olivier RM Chlorpromazine-induced anticardiolipm antibodies and lupus anticoagulant [resumen]. Arthritis Rheum 1986; 29 596.
48. Hughes GRV. The antiphospholipid syndrome: ten years on. Lancet 1993: 342- 341-344.
49. Amigo MC, Garcia Torres R, Robles M, Bochicchio T. Reyes PA. Renal involvement in primary antiphospholipid syndrome J Rheumatol 1992; 19: 1.181-1.185.
50. Piette JC. Cacoub P. Wechsler B. Renal manifestations of the antiphospholipid syndrome Semin Arthritis Rheum 1994; 23 357-366
51. Greisman SG, Thayaparan RS, Godwin TA et al. Occlusive vasculopathy in systemic lupus erythematosus: association with anti-cardiolipin antibody Arch Intern Med 1991; 151. 389-392
52. Branch DW. Thoughts on the mechanism of pregnancy loss associated with the antiphospholipid syndrome. Lupus 1994, 3: 275-280
53. Cuadrado MJ, Mujic F, Muǹoz E, Khamashta MA. Hughes GRV Thrombucytopenia in antiphospholipid syndrome. Lupus 1995; 4 121.
54. Toubi E, Khamashta MA. Panarra A, Hughes GRV Association of antiphospholipid antibodies with central nervous system disease in SLE. Am J Med 1995: 99 397-401
55. Lima F, Khamashta MA. Buchannam MMN, Kerslake S, Hughes GRV Study of sixty pregnancies in patients with antiphosphohpid syndrome. Clin Exp Rheumatol 1996; 14: 131136
56. Brandt JT. The effect of lupus anticoagulant on the expression of tissue factor activity 7v cultured endothelial cells [resumenl. Thromb Haemost 1991, 65: 673.
57. Groot PG, Derksen RHWM. Protein C pathway, antiphospholipid antibodies and thrombosis Lupus 1994; 3: 229-233
58. Khamashta MA, Harris RN, Gharavi AE et al Immune mediated mechanism for thrombosis antiphospholipid antibody binding to platelet membranes Ann Rheum Dis 1988; 47849-854.
59. Escolar G, Font J, Reverter JC et al. Plasma from systemic lupus erythematosus patients with antiphospholipid antibodies promotes platelet agregation: studies m a perfusion system Arteriosclerosis 1992, 12 196-200.